By: Statement | July 25, 2014
The Advanced Medical Technology Association (AdvaMed) today issued a statement by Stephen J. Ubl, president and CEO, commending a call by Members of Congress for the Office of the Inspector General (OIG) to study the impact of competitive bidding on patients.
By: Statement | July 22, 2014
“AdvaMed applauds the subcommittee for holding this important hearing on barriers to evidence development and improving communication and collaboration among patients, providers, researchers, and medical technology companies to ensure continued development of the latest treatments and cures.
By: Statement | July 17, 2014
“The new Milken Institute report released today is an important assessment on how improved patient access to innovative medical technology can provide tremendous value to the U.S. economy, both now and in the future.